| Literature DB >> 34983125 |
Ming-Chieh Cheng1, Shih-Ping Liu1, Yao-Chi Chuang2, Karina Chin Po Hsu3, Po-Ming Chow4.
Abstract
PURPOSE: Male urinary incontinence (UI) is a global health issue associated with bothersome symptoms which affect daily life. This study aims to evaluate the prevalence of male UI in China, Taiwan, and South Korea and to determine if UI is an independent risk factor affecting the health-related quality of life (HRQoL), mental health, work limitations, and healthcare seeking behavior.Entities:
Keywords: Health care seeking behavior; Male genitourinary diseases; Mental health; Quality of life; Work performance
Mesh:
Year: 2022 PMID: 34983125 PMCID: PMC8756147 DOI: 10.4111/icu.20210259
Source DB: PubMed Journal: Investig Clin Urol ISSN: 2466-0493
Demographic data
| Total participants (n=4,076) | No UI (n=3,369) | UUI only (n=222) | SUI only (n=206) | Mixed UI (n=278) | |
|---|---|---|---|---|---|
| Age (y) | |||||
| 40–44 | 665 (19.7) | 32 (14.4) | 29 (14.1) | 31 (11.2) | |
| 45–49 | 656 (19.5) | 35 (15.8) | 21 (10.2) | 39 (14.0) | |
| 50–54 | 571 (16.9) | 33 (14.9) | 29 (14.1) | 26 (9.4) | |
| 55–59 | 468 (13.9) | 30 (13.5) | 24 (11.7) | 44 (15.8) | |
| ≥60 | 1,010 (30.0) | 92 (41.4) | 103 (50.0) | 139 (50.0) | |
| Education | |||||
| High school or less | 868 (25.8) | 48 (21.6) | 63 (30.6) | 62 (22.3) | |
| Some college | 671 (19.9) | 40 (18.0) | 53 (25.7) | 71 (25.5) | |
| College graduate | 1,516 (45.0) | 116 (52.3) | 84 (40.8) | 130 (46.8) | |
| Postgraduate | 313 (9.3) | 18 (8.1) | 6 (2.9) | 15 (5.4) | |
| Marital status | |||||
| Single | 277 (8.2) | 16 (7.2) | 5 (2.4) | 9 (3.2) | |
| Divorced | 106 (3.1) | 5 (2.3) | 3 (1.5) | 3 (1.1) | |
| Married/living with partner | 2,892 (85.8) | 194 (87.4) | 189 (91.7) | 264 (95.0) | |
| Widow/widower | 68 (2.0) | 8 (3.6) | 9 (4.4) | 3 (1.1) | |
| Prefer not to answer | 28 (0.8) | 0 (0.0) | 1 (0.5) | 0 (0.0) | |
| Work status | |||||
| Working, full-time | 2,389 (70.9) | 134 (60.4) | 116 (56.3) | 153 (55.0) | |
| Retired | 613 (18.2) | 50 (22.5) | 69 (33.5) | 102 (36.7) | |
| Homemaker | 27 (0.8) | 0 (0.0) | 3 (1.5) | 0 (0.0) | |
| Working, part-time | 155 (4.6) | 20 (9.0) | 8 (3.9) | 18 (6.5) | |
| Other | 71 (2.1) | 7 (3.2) | 4 (1.9) | 2 (0.7) | |
| Unemployed | 48 (1.4) | 3 (1.4) | 0 (0.0) | 1 (0.4) | |
| Other work for pay | 58 (1.7) | 5 (2.3) | 1 (0.5) | 1 (0.4) | |
| Permanently disabled/cannot work due to ill health | 6 (0.2) | 3 (1.4) | 4 (1.9) | 1 (0.4) | |
| Student | 2 (0.1) | 1 (0.5) | 1 (0.5) | 0 (0.0) | |
Values are presented as number (%).
UI, urinary incontinence; UUI, urge urinary incontinence; SUI, stress urinary incontinence.
Baseline comorbidities and symptoms
| Variable | No UI (n=3,369) | UUI only (n=222) | SUI only (n=206) | Mixed UI (n=278) |
|---|---|---|---|---|
| Age (y) | 53.46±9.14 | 55.81±9.61 | 56.88±9.70 | 57.33±9.44 |
| Diabetes | 361 (10.7) | 41 (18.5) | 51 (24.8) | 113 (40.6) |
| Hypertension | 1,095 (32.5) | 99 (44.6) | 100 (48.5) | 167 (60.1) |
| Cardiac disease | 202 (6.0) | 33 (14.9) | 29 (14.1) | 58 (20.9) |
| Hyperlipidemia | 1,019 (30.2) | 91 (41.0) | 76 (36.9) | 144 (51.8) |
| Neurological disorder | 52 (1.5) | 11 (5.0) | 6 (2.9) | 33 (11.9) |
| Height (cm) | 170.54±6.10 | 169.76±5.81 | 169.55±7.71 | 170.55±5.98 |
| Weight (kg) | 70.38±10.76 | 68.91±11.72 | 68.13±10.43 | 69.57±9.59 |
| Body mass index (kg/m2) | 24.17±3.34 | 23.86±3.56 | 23.74±3.55 | 23.93±3.36 |
| Smoking | 1,184 (35.1) | 108 (48.6) | 92 (44.7) | 169 (60.8) |
| Alcohol | 1,013 (30.1) | 100 (45.0) | 64 (31.1) | 156 (56.1) |
| IPSS, incomplete emptying | 0.92±1.24 | 2.29±1.52 | 1.91±1.29 | 2.56±1.24 |
| IPSS, frequency | 0.99±1.19 | 2.37±1.32 | 1.91±1.17 | 2.58±1.27 |
| IPSS, intermittency | 0.61±1.03 | 1.96±1.49 | 1.62±1.24 | 2.47±1.25 |
| IPSS, urgency | 0.46±0.84 | 2.10±1.34 | 1.49±1.18 | 2.37±1.25 |
| IPSS, weak stream | 0.71±1.18 | 2.05±1.52 | 1.66±1.37 | 2.51±1.34 |
| IPSS, straining | 0.51±0.95 | 1.82±1.48 | 1.56±1.33 | 2.36±1.30 |
| IPSS, nocturia | 1.18±1.20 | 2.04±1.29 | 1.99±1.24 | 2.64±1.28 |
| IPSS, total | 5.38±5.46 | 14.62±6.95 | 12.15±6.3 | 17.48±6.85 |
| IPSS, voiding score | 1.83±2.71 | 5.82±3.79 | 4.85±3.42 | 7.33±3.37 |
| ICS, splitting/spraying | 0.79±1.13 | 1.88±1.45 | 1.68±1.31 | 2.44±1.30 |
| ICS, hesitancy | 0.52±0.89 | 1.62±1.40 | 1.45±1.30 | 2.21±1.28 |
| ICS, terminal dribble | 0.94±1.22 | 2.47±1.47 | 1.96±1.37 | 2.77±1.21 |
| ICS, urgency with a fear of leaking | 0.33±0.70 | 1.95±1.30 | 1.41±1.26 | 2.49±1.14 |
| ICS, urgency incontinence | 1±0 | 2.46±0.67 | 1±0 | 2.61±0.72 |
| OABSS | 1.96±1.76 | 5.52±2.30 | 4.59±2.43 | 7.07±2.56 |
| Generic HRQoL-SF12 | 36.75±6.08 | 31.17±6.59 | 29.28±5.60 | 27.00±5.48 |
| HADS, anxiety score | 4.55±3.45 | 7.21±3.70 | 7.46±3.01 | 8.94±3.47 |
| HADS, depression score | 5.06±3.54 | 7.46±3.63 | 7.52±3.02 | 8.79±3.59 |
| IIEF (male only) | 16.55±7.38 | 12.91±7.24 | 12.19±6.56 | 12.07±5.54 |
Values are presented as mean±standard deviation or number (%).
UI, urinary incontinence; UUI, urge urinary incontinence; SUI, stress urinary incontinence; IPSS, International Prostate Symptom Score; ICS, International Continence Society; OABSS, Overactive Bladder Symptom Score; HRQoL-SF12, health-related quality of life 12-item short-form survey; HADS, Hospital Anxiety and Depression Scale; IIEF, International Index of Erectile Function.
Fig. 1Age-wise prevalence of urinary incontinence in males. UUI, urge urinary incontinence; SUI, stress urinary incontinence; UI, urinary incontinence.
Linear regression analysis showing variables independently associated with HRQoL in physical and mental health domains
| Linear regression for HRQoL | Physical health domain | Mental health domain | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate | Univariate analysis | Multivariate | |||||
| Coefficient (95% CI) | p-value | Coefficient (95% CI) | p-value | Coefficient (95% CI) | p-value | Coefficient (95% CI) | p-value | |
| Age (numerical) | -0.478 (-0.543 to -0.413) | <0.001 | -0.184 (-0.226 to -0.142) | <0.001 | ||||
| Age (>60 y) | -8.635 (-9.970 to -7.300) | <0.001 | -3.888 (-5.024 to -2.751) | <0.001 | -3.823 (-4.681 to -2.965) | <0.001 | -1.149 (-1.914 to -0.384) | 0.003 |
| Married | -1.416 (-3.664 to 0.833) | 0.217 | 0.084 (-1.347 to 1.515) | 0.908 | ||||
| Diabetes | -15.580 (-17.299 to -13.862) | <0.001 | -6.099 (-7.615 to -4.583) | <0.001 | -7.519 (-8.630 to -6.408) | <0.001 | -2.177 (-3.198 to -1.157) | <0.001 |
| Hypertension | -9.959 (-11.209 to -8.709) | <0.001 | -3.705 (-4.829 to -2.580) | <0.001 | -4.473 (-5.280 to -3.666) | <0.001 | -1.195 (-1.952 to -0.438) | 0.002 |
| Cardiac disease | -15.435 (-17.676 to -13.195) | <0.001 | -6.177 (-8.096 to -4.257) | <0.001 | -8.109 (-9.544 to -6.673) | <0.001 | -3.097 (-4.389 to -1.805) | <0.001 |
| Hyperlipidemia | -6.616 (-7.916 to -5.316) | <0.001 | -1.255 (-2.384 to -0.126) | 0.029 | -2.964 (-3.796 to -2.131) | <0.001 | -0.135 (-0.895 to 0.625) | 0.727 |
| Neurological disorder | -21.435 (-25.325 to -17.544) | <0.001 | -9.234 (-12.520 to -5.947) | <0.001 | -13.710 (-16.180 to -11.230) | <0.001 | -7.304 (-9.516 to -5.092) | <0.001 |
| Height (numerical) | 0.246 (0.146 to 0.345) | <0.001 | 0.160 (0.096 to 0.223) | <0.001 | ||||
| Weight (numerical) | 0.029 (-0.029 to 0.086) | 0.324 | 0.044 (0.007 to 0.080) | 0.018 | ||||
| BMI (numerical) | -0.172 (-0.356 to 0.011) | 0.066 | -0.126 (-0.279 to -0.027) | 0.107 | -0.024 (-0.140 to 0.093) | 0.692 | -0.036 (-0.139 to 0.067) | 0.490 |
| Smoking | -4.847 (-6.108 to -3.585) | <0.001 | -1.488 (-2.563 to -0.413) | 0.007 | -2.889 (-3.693 to -2.086) | <0.001 | -0.915 (-1.638 to -0.191) | 0.013 |
| Alcohol | -3.264 (-4.575 to -1.952) | <0.001 | 1.213 (0.100 to 2.327) | 0.033 | -1.920 (-2.754 to -1.085) | <0.001 | 0.605 (-0.144 to 1.355) | 0.114 |
| PPBC | -9.135 (-9.630 to -8.639) | <0.001 | -5.051 (-5.704 to -4.399) | <0.001 | -5.276 (-5.600 to -4.952) | <0.001 | -2.982 (-3.421 to -2.543) | <0.001 |
| IPSS-V score | -2.651 (-2.818 to -2.484) | <0.001 | -0.670 (-0.878 to -0.462) | <0.001 | -1.517 (-1.625 to -1.408) | <0.001 | -0.389 (-0.529 to -0.249) | <0.001 |
| OABSS (numerical) | -4.428 (-4.641 to -4.215) | <0.001 | -2.580 (-2.720 to -2.441) | <0.001 | ||||
| UUI | -21.857 (-23.612 to -20.101) | <0.001 | -2.252 (-4.160 to -0.343) | 0.021 | -12.897 (-14.025 to -11.769) | <0.001 | -1.524 (-2.809 to -0.240) | 0.020 |
| SUI | -24.538 (-26.289 to -22.786) | <0.001 | -8.591 (-10.465 to -6.717) | <0.001 | -14.690 (-15.816 to -13.564) | <0.001 | -5.963 (-7.224 to -4.701) | <0.001 |
| Daily SUI | -26.198 (-32.134 to -20.263) | <0.001 | -16.619 (-20.394 to -12.843) | <0.001 | ||||
HRQoL, health-related quality of life; CI, confidence interval; BMI, body mass index; PPBC, Patient Perception of Bladder Condition; IPSS-V, International Prostate Symptom Score-Voiding; OABSS, Overactive Bladder Symptom Score; UUI, urge urinary incontinence; SUI, stress urinary incontinence.
Fig. 2Impact of urinary incontinence on HRQoL. HRQoL, health-related quality of life; UI, urinary incontinence; UUI, urge urinary incontinence; SUI, stress urinary incontinence; MUI, mixed urinary incontinence; SF12, 12-item short-form survey.
Logistic regression analysis showing independent variables associated with HADS anxiety and depression scores
| Logistic regression for HADS score ≥8 | HADS anxiety | HADS depression | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
| Coefficient (95% CI)a | p-value | Coefficient (95% CI)a | p-value | Coefficient (95% CI)a | p-value | Coefficient (95% CI)a | p-value | |
| Age (numerical) | 1.005 (0.998–1.013) | 0.156 | 1.022 (1.015–1.030) | <0.001 | ||||
| Age (>60 y) | 1.150 (0.987–1.341) | 0.073 | 0.736 (0.615–0.881) | 0.001 | 1.475 (1.277–1.703) | <0.001 | 1.043 (0.885–1.228) | 0.616 |
| Married | 1.035 (0.799–1.340) | 0.796 | 0.690 (0.547–0.870) | 0.002 | ||||
| Diabetes | 2.010 (1.667–2.422) | <0.001 | 1.018 (0.814–1.274) | 0.876 | 2.065 (1.722–2.476) | <0.001 | 1.113 (0.901–1.374) | 0.320 |
| Hypertension | 1.877 (1.626–2.167) | <0.001 | 1.427 (1.202–1.693) | <0.001 | 1.972 (1.719–2.262) | <0.001 | 1.470 (1.253–1.725) | <0.001 |
| Cardiac disease | 2.090 (1.652–2.644) | <0.001 | 1.192 (0.900–1.577) | 0.220 | 2.069 (1.643–2.606) | <0.001 | 1.185 (0.907–1.547) | 0.213 |
| Hyperlipidemia | 1.362 (1.175–1.577) | <0.001 | 0.861 (0.722–1.027) | 0.097 | 1.496 (1.300–1.720) | <0.001 | 1.028 (0.873–1.209) | 0.744 |
| Neurological disorder | 5.468 (3.628–8.242) | <0.001 | 3.587 (2.246–5.727) | <0.001 | 5.550 (3.623–8.504) | <0.001 | 3.532 (2.209–5.648) | <0.001 |
| Height (numerical) | 0.998 (0.987–1.010) | 0.757 | 0.984 (0.974–0.995) | 0.003 | ||||
| Weight (numerical) | 0.995 (0.989–1.002) | 0.169 | 0.993 (0.986–0.999) | 0.021 | ||||
| BMI (numerical) | 0.987 (0.966–1.008) | 0.222 | 0.988 (0.964–1.012) | 0.322 | 0.990 (0.970–1.010) | 0.333 | 0.988 (0.965–1.010) | 0.279 |
| Smoking | 1.618 (1.402–1.866) | <0.001 | 1.202 (1.018–1.419) | 0.030 | 1.445 (1.261–1.656) | <0.001 | 1.182 (1.012–1.382) | 0.035 |
| Alcohol | 1.652 (1.427–1.911) | <0.001 | 1.153 (0.972–1.366) | 0.102 | 1.305 (1.134–1.502) | <0.001 | 0.913 (0.777–1.075) | 0.275 |
| PPBC | 2.064 (1.928–2.210) | <0.001 | 1.424 (1.298–1.562) | <0.001 | 1.920 (1.798–2.050) | <0.001 | 1.360 (1.244–1.487) | <0.001 |
| IPSS-V score | 1.266 (1.239–1.294) | <0.001 | 1.134 (1.101–1.167) | <0.001 | 1.251 (1.224–1.278) | <0.001 | 1.139 (1.107–1.171) | <0.001 |
| OABSS (numerical) | 1.409 (1.365–1.454) | <0.001 | 1.356 (1.316–1.397) | <0.001 | ||||
| UUI | 5.187 (4.269–6.303) | <0.001 | 1.288 (0.999–1.660) | 0.051 | 3.863 (3.187–4.683) | <0.001 | 1.024 (0.795–1.317) | 0.856 |
| SUI | 5.250 (4.309–6.398) | <0.001 | 1.719 (1.339–2.207) | <0.001 | 4.082 (3.356–4.965) | <0.001 | 1.388 (1.084–1.776) | 0.009 |
| Daily SUI | 6.386 (3.367–12.112) | <0.001 | 7.611 (3.781–15.32) | <0.001 | ||||
HADS, Hospital Anxiety and Depression Scale; CI, confidence interval; BMI, body mass index; PPBC, Patient Perception of Bladder Condition; IPSS-V, International Prostate Symptom Score-Voiding; OABSS, Overactive Bladder Symptom Score; UUI, urge urinary incontinence; SUI, stress urinary incontinence.
a:≤1 is negative effect; >1 is positive effect on HADS ≥8.
Logistic regression analysis showing impact of independent variables on work performance
| Logistic regression for work difficulty in ≥50% of the time | Start working | Continue working | Concentrate on working | Interact with people | Complete the work | Number of significant impacts | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Coefficienta | p-value | Coefficienta | p-value | Coefficienta | p-value | Coefficienta | p-value | Coefficienta | p-value | ||
| Age (numerical) | 1.006 | 0.258 | 0.992 | 0.016 | 1.018 | <0.001 | 1.017 | 0.003 | 1.009 | 0.114 | 2 |
| Age (>60 y) | 1.094 | 0.415 | 0.865 | 0.047 | 1.407 | 0.001 | 1.356 | 0.008 | 1.265 | 0.032 | 1 |
| Married | 1.353 | 0.157 | 1.171 | 0.209 | 1.091 | 0.637 | 1.085 | 0.699 | 1.185 | 0.408 | 0 |
| Diabetes | 3.586 | <0.001 | 1.309 | 0.004 | 3.193 | <0.001 | 3.779 | <0.001 | 2.989 | <0.001 | 5 |
| Hypertension | 2.001 | <0.001 | 1.029 | 0.676 | 1.529 | <0.001 | 1.686 | <0.001 | 1.615 | <0.001 | 4 |
| Cardiac disease | 3.393 | <0.001 | 1.599 | <0.001 | 2.727 | <0.001 | 3.033 | <0.001 | 2.676 | <0.001 | 5 |
| Hyperlipidemia | 1.722 | <0.001 | 1.227 | 0.003 | 1.342 | 0.003 | 1.243 | 0.052 | 1.270 | 0.024 | 3 |
| Neurological disorder | 6.130 | <0.001 | 1.632 | 0.016 | 6.017 | <0.001 | 7.553 | <0.001 | 4.116 | <0.001 | 4 |
| Height | 1.006 | 0.470 | 1.015 | 0.006 | 1.005 | 0.524 | 0.988 | 0.165 | 1.005 | 0.536 | 0 |
| Weight | 1.001 | 0.793 | 1.005 | 0.092 | 0.993 | 0.101 | 0.990 | 0.060 | 0.998 | 0.630 | 0 |
| BMI | 0.999 | 0.950 | 1.004 | 0.657 | 0.972 | 0.051 | 0.980 | 0.229 | 0.991 | 0.555 | 0 |
| Smoking | 1.597 | <0.001 | 1.136 | 0.060 | 1.779 | <0.001 | 1.756 | <0.001 | 1.560 | <0.001 | 4 |
| Alcohol | 1.853 | <0.001 | 1.331 | <0.001 | 1.737 | <0.001 | 1.581 | <0.001 | 1.701 | <0.001 | 5 |
| PPBC | 2.333 | <0.001 | 1.240 | <0.001 | 2.166 | <0.001 | 2.117 | <0.001 | 2.034 | <0.001 | 5 |
| IPSS-V score | 1.297 | <0.001 | 1.083 | <0.001 | 1.300 | <0.001 | 1.276 | <0.001 | 1.264 | <0.001 | 5 |
| OABSS (numerical) | 1.602 | <0.001 | 1.101 | <0.001 | 1.540 | <0.001 | 1.548 | <0.001 | 1.494 | <0.001 | 5 |
| UUI | 8.858 | <0.001 | 2.029 | <0.001 | 7.512 | <0.001 | 8.329 | <0.001 | 6.889 | <0.001 | 5 |
| SUI | 11.320 | <0.001 | 1.624 | <0.001 | 9.218 | <0.001 | 10.651 | <0.001 | 8.173 | <0.001 | 5 |
| Daily SUI | 59.918 | <0.001 | 4.794 | <0.001 | 17.881 | <0.001 | 28.258 | <0.001 | 31.125 | <0.001 | 5 |
HADS, Hospital Anxiety and Depression Scale; BMI, body mass index; PPBC, Patient Perception of Bladder Condition; IPSS-V, International Prostate Symptom Score-Voiding; OABSS, Overactive Bladder Symptom Score; UUI, urge urinary incontinence; SUI, stress urinary incontinence.
a:≤1 is negative effect; >1 is positive effect on HADS ≥8.
Fig. 3Frequency-distribution of triggers for stress urinary incontinence.
Fig. 4Impact of type of UI on healthcare seeking behaviors. UI, urinary incontinence; UUI, urge urinary incontinence; SUI, stress urinary incontinence; MUI, mixed urinary incontinence.